-
AMLX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Amylyx Pharmaceuticals (AMLX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 73.28 mm | 73.28 mm | 73.28 mm | 73.28 mm | 73.28 mm | 73.28 mm |
Cash burn (monthly) | 812.67 k | 5.22 mm | 25.22 mm | 22.30 mm | 13.86 mm | 7.92 mm |
Cash used (since last report) | 3.27 mm | 21.02 mm | 101.49 mm | 89.73 mm | 55.76 mm | 31.89 mm |
Cash remaining | 70.01 mm | 52.26 mm | -28.21 mm | -16.45 mm | 17.52 mm | 41.39 mm |
Runway (months of cash) | 86.1 | 10.0 | -1.1 | -0.7 | 1.3 | 5.2 |
13F holders | Current |
---|---|
Total holders | 115 |
Opened positions | 23 |
Closed positions | 32 |
Increased positions | 32 |
Reduced positions | 35 |
13F shares | Current |
---|---|
Total value | 133.35 bn |
Total shares | 54.57 mm |
Total puts | 502.90 k |
Total calls | 210.60 k |
Total put/call ratio | 2.4 |
Largest owners | Shares | Value |
---|---|---|
TCG Crossover Management | 4.64 mm | $15.05 bn |
TCG Crossover GP II | 4.64 mm | $10.26 mm |
Panacea Innovation | 4.20 mm | $14.11 mm |
Vanguard | 3.09 mm | $10.01 bn |
BlackRock | 2.55 mm | $8.26 bn |
Morningside Venture Investments | 2.31 mm | $43.30 mm |
Perceptive Advisors | 2.13 mm | $6.89 bn |
Alyeska Investment | 2.02 mm | $6.56 bn |
683 Capital Management | 2.00 mm | $6.48 bn |
Almitas Capital | 1.99 mm | $6.44 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 Jan 25 | Milne George M JR | Common Stock | Gift | Dispose G | No | No | 0 | 27,910 | 0.00 | 830,661 |
6 Jan 25 | Justin B. Klee | Common Stock | Sell | Dispose S | No | No | 4.0425 | 7,471 | 30.20 k | 3,176,788 |
6 Jan 25 | Joshua B Cohen | Common Stock | Sell | Dispose S | No | No | 4.0466 | 7,471 | 30.23 k | 3,213,098 |
2 Dec 24 | Camille L Bedrosian | Common Stock | Sell | Dispose S | No | No | 5.5354 | 5,421 | 30.01 k | 138,380 |
4 Nov 24 | Justin B. Klee | Common Stock | Option exercise | Acquire M | No | No | 1.57 | 63,690 | 99.99 k | 3,184,259 |
4 Nov 24 | Justin B. Klee | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.57 | 63,690 | 99.99 k | 36,310 |